AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea
· Delayed Price · Currency is KRW
8,510.00
+60.00 (0.71%)
At close: Dec 5, 2025
AptaBio Therapeutics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -20,227 | -29,378 | -12,062 | -10,565 |
| Depreciation & Amortization | 508.71 | 531.35 | 539.11 | 484.62 |
| Loss (Gain) From Sale of Investments | -1,042 | 583.55 | 244.29 | 2,494 |
| Loss (Gain) on Equity Investments | -879.7 | 583.5 | 4.19 | - |
| Stock-Based Compensation | 253.89 | 234.34 | 186.65 | 123.6 |
| Other Operating Activities | 8,480 | 12,478 | -2,458 | 631.31 |
| Change in Accounts Receivable | -85.48 | -893.71 | - | - |
| Change in Inventory | -131.35 | -224.87 | - | - |
| Change in Accounts Payable | 39.35 | 1.87 | - | - |
| Change in Other Net Operating Assets | -2,331 | 3,924 | -549.77 | -1.91 |
| Operating Cash Flow | -15,377 | -12,160 | -14,095 | -6,833 |
| Capital Expenditures | -291.74 | -240.16 | -1,345 | -1,041 |
| Sale (Purchase) of Intangibles | - | - | -46.6 | -10.36 |
| Sale (Purchase) of Real Estate | - | - | - | -65.94 |
| Investment in Securities | 4,871 | 13,521 | -9,006 | 5,332 |
| Other Investing Activities | -49.94 | -55.62 | 60.15 | 27.66 |
| Investing Cash Flow | 2,769 | 12,854 | -12,737 | 1,743 |
| Long-Term Debt Issued | - | - | 38,900 | - |
| Long-Term Debt Repaid | - | -134.01 | -127.85 | -87.95 |
| Net Debt Issued (Repaid) | -650.28 | -134.01 | 38,772 | -87.95 |
| Issuance of Common Stock | - | - | - | 589.2 |
| Other Financing Activities | -20.94 | -33.3 | -19.2 | -5.24 |
| Financing Cash Flow | -671.22 | -167.31 | 49,854 | 496.01 |
| Foreign Exchange Rate Adjustments | -10.69 | -1.19 | 5.07 | 16.76 |
| Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | 0 |
| Net Cash Flow | -13,290 | 525.33 | 23,027 | -4,577 |
| Free Cash Flow | -15,669 | -12,400 | -15,440 | -7,874 |
| Free Cash Flow Margin | -455.40% | -368.94% | -4767.39% | -16284.04% |
| Free Cash Flow Per Share | -622.58 | -526.67 | -692.42 | -353.27 |
| Cash Interest Paid | 8.61 | 10.2 | 11.47 | 4.49 |
| Cash Income Tax Paid | - | 76.18 | 48.45 | -34.01 |
| Levered Free Cash Flow | -17,255 | -1,924 | -13,398 | - |
| Unlevered Free Cash Flow | -15,931 | 201.3 | -12,659 | - |
| Change in Working Capital | -2,508 | 2,807 | -549.77 | -1.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.